Tissue engineering, or regenerative medicine, is a growing research field that may offer alternative therapies to patients with serious urological defects. Tissue engineering uses a combination of cells, engineered materials and other biochemical factors to create functional tissue. The goal is to restore, maintain or improve damaged tissues or whole organs.
“Tissue engineering may be required any time there’s an injured tissue or organ that requires replacement or repair due to trauma, congenital conditions or conditions from acquired pathologic diseases,” said Anthony Atala, MD, Director of the Wake Forest Institute for Regenerative Medicine and the W. Boyce Professor and Chair of Urology at Wake Forest University.
Dr. Atala will moderate a 30-minute critical discussion titled Tissue Engineering 2018 during Sunday afternoon’s Next Frontier plenary session. During the discussion, which begins at 1:15 pm in Hall E at Moscone North, Dr. Atala and two regenerative medicine experts will discuss recent advances and the future of tissue engineering.
“Early research into regenerative medicine used engineered tissue to perform simple repairs to defects in functional organs. More recently, complex therapies are entering the clinic and nearly every urologic tissue has been studied by regenerative medicine experts,”Dr. Atala said.
“There are now clinical trials for kidney disease that use tissue engineering,” he said. “There are applications of tissue engineering for urology extending into the areas of other organs as well, such as engineered urethras, vaginal organs, bladders and even penile tissue.”
Dr. Atala will open the discussion with a basic introduction to the field of tissue engineering. He will be joined in the critical discussion by Christopher Chapple, BSc, ME, FRCS (Urol), FEBU, Consultant Urological Surgeon at Sheffield Teaching Hospitals, Honorary Professor at University of Sheffield and Visiting Professor at Sheffield Hallam University, who will discuss tissue engineering for pelvic disease. Janos Peti Peterdi, MD, PhD, professor at the Departments of Physiology and Neuroscience, and Medicine at the University of Southern California, will discuss advances in kidney engineering.
“I hope that attendees will leave this session having learned about some of the new applications in the field of tissue engineering,” Dr. Atala said. “It should provide an update on the current applications and preview some of the future directions of the field.”